Skip to content
Menu

NRx Pharmaceuticals, Inc. NRXP

Full chart Compare
Set alert

Price alert · NRXP

All alert types
2.62 USD -0.18 (-6.42%)

As ofNov 19, 2026, 1:05 PM EST

2.62 Day range 2.88
1.62 52-week range 5.06
YTD
-3.32%
1 year
+23.01%

Discussion (134)

Ellie Menkaure NRXP 5 years ago #72

All CAPS person, an employee of $NXRP did not write the preprinted article. It was a Principal Investigator at one of the sites. They made a mistake and probably didn’t fully understand the EUA submission statuses yet. Not as big of a deal as you are making it out to be. It was corrected. Move on! If you don’t like the company and you don’t trust them, then pick another stock. Many many other stocks to choose from.

Ellie Menkaure NRXP 5 years ago #73

$NRXP Why are people posting conspiracy theories about the Pfizer vaccine on this discussion? If you don’t know how clinical trials work or how to find reliable scientific articles, stop spreading misinformation. Go read the clinical trial synopsis for the Pfizer vaccine trial on clinicaltrials.gov. The length of time they are collecting data and the antibody measurements are listed as secondary outcome measures. https://clinicaltrials.gov/ct2/show/NCT04368728. The trial got fast track designation by the FDA, the trial had unique advantages in that there was a global outbreak (east exposures) and they had 44,000 participants (typical vaccine trials are 3,000-6,000). They also did the phases in parallel. They have plenty of data to approve the vaccine. If you don’t know what it takes to get a drug approved, stop complaining that it shouldn’t have been approved.

Ellie Menkaure NRXP 5 years ago #75

All Caps person. FDA told Novartis to hold off on submission for EUA approval because there are manufacturing delays. $NRXP just did a DSMB meeting which means they just submitted additional data to the FDA. FDA might have requested additional data. As for 140 patients in 4 months from 35 sites, obviously you don’t know anything about clinical trials. Those aren’t bad numbers given how specific of a population this is targeting.

Tanner NRXP 5 years ago #76

$NRXP the old pump and dump, if you are invested in this , get used to it

dlee413 NRXP 5 years ago #77

Just added 1500 more shares at this price. This is a no brainer investment. Just do your dd and relax.

dlee413 NRXP 5 years ago #78

Conference call was promising to me. I expect great things soon

dlee413 NRXP 5 years ago #79

Do you guys have the link for the webcast or the phone number to call into to listen to ER. Thanks

Ellie Menkaure NRXP 5 years ago #80

Stop posting all caps about the pre-published article if you don’t know how research works. The article is on a website where abstracts can be posted for public access months or even years before they are published in a reputable peer reviewed journal. The authors of the abstract are Principal Investigators (contracted to run the clinical trial at their hospital or research center). I highly doubt the mistake was on purpose by the actual writers of the abstract. More than likely, Dr. Javitt had not reviewed the abstract (even though he is listed as 3rd author). The statement in the article is accurate (Emergency use approval in Georgia and it has expanded access use authorization in the US). There are typos all over in this article so I wouldn’t base everything on this since it obviously hasn’t been thoroughly reviewed (probably by most of the authors).

Sign in to join the discussion